Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) is 27.72% higher on its value in year-to-date trading and has touched a low of $13.12 and a high of $24.27 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CPRX stock was last observed hovering at around $21.91 in the last trading session, with the day’s loss setting it -0.44%.
Currently trading at $21.47, the stock is -1.27% and -1.47% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.99 million and changing -2.01% at the moment leaves the stock 16.75% off its SMA200. CPRX registered 24.18% gain for a year compared to 6-month gain of 38.61%. The firm has a 50-day simple moving average (SMA 50) of $21.79 and a 200-day simple moving average (SMA200) of $18.38995.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -2.10% loss in the last 1 month and extending the period to 3 months gives it a 9.76%, and is 0.05% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.13% over the week and 3.08% over the month.
Catalyst Pharmaceuticals Inc (CPRX) has around 167 employees, a market worth around $2.51B and $460.48M in sales. Current P/E ratio is 18.32 and Fwd P/E is 13.52. Profit margin for the company is 31.01%. Distance from 52-week low is 63.69% and -11.54% from its 52-week high. The company has generated returns on investments over the last 12 months (21.51%).
with sales reaching $134.12M over the same period.The EPS is expected to grow by 93.39% this year, but quarterly earnings will post 21.55% year-over-year. Quarterly sales are estimated to grow 21.30% in year-over-year returns.
Catalyst Pharmaceuticals Inc (CPRX) Top Institutional Holders
437.0 institutions hold shares in Catalyst Pharmaceuticals Inc (CPRX), with institutional investors hold 88.13% of the company’s shares. The shares outstanding are 119.27M, and float is at 105.53M with Short Float at 5.63%. Institutions hold 82.59% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 18.69 million shares valued at $289.58 million. The investor’s holdings represent 16.0051% of the CPRX Shares outstanding. As of 2024-06-30, the second largest holder is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) with 9.13 million shares valued at $141.38 million to account for 7.8141 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 8.1 million shares representing 6.9349% and valued at over $125.47 million, while STATE STREET CORP holds 5.1652 of the shares totaling 6.03 million with a market value of $93.46 million.
Catalyst Pharmaceuticals Inc (CPRX) Insider Activity
The most recent transaction is an insider sale by Miller Steve, the company’s Chief Op. & Scientific Officer. SEC filings show that Miller Steve sold 50,000 shares of the company’s common stock on Dec 10 ’24 at a price of $21.93 per share for a total of $1.1 million. Following the sale, the insider now owns 0.69 million shares.
Still, SEC filings show that on Nov 27 ’24, INGENITO GARY (Chief Med. & Reg. Officer) disposed off 12,000 shares at an average price of $22.72 for $0.27 million. The insider now directly holds 51,391 shares of Catalyst Pharmaceuticals Inc (CPRX).
